Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05988073 · ClinicalTrials.gov registry record
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
A clinical trial of Multifocal Motor Neuropathy, sponsored by argenx.
- Active
- Registry status
- 413
- Enrollment target
- 20
- Study locations
NCT05988073: Active study of Multifocal Motor Neuropathy, sponsored by argenx.
NCT05988073 is a study of Multifocal Motor Neuropathy that is active but no longer recruiting, run by argenx. The registered enrollment target is 413 participants. The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05988073, a study of Multifocal Motor Neuropathy, is active but no longer recruiting, sponsored by argenx.
- ACTIVE NOT RECRUITING
- Registry status
- 413 participants
- Enrollment target
- 20
- Study locations
Study Summary
This prospective longitudinal study will follow participants with Multifocal Motor Neuropathy over time and collect data on their clinical outcomes, quality of life, and use of health care resources. Participants will follow their regular visit schedule with their treating physician, except for an optional second visit occurring 7 to 14 days after the start of the study to collect biomarker data. No IMP will be administered.
Conditions Studied
Study Locations (20)
California
- UCI Health - ALS and Neuromuscular Center - Orange
- Stanford Medicine Health Care - Stanford Neuroscience Health Center - Palo Alto
- The Neurology Group - Pomona
- Eisenhower Health - Rancho Mirage Medical Center - Rancho Mirage
- UC Davis Health - Lawrence J. Ellison Ambulatory Care Center - Sacramento
- UCSF Health - UCSF Medical Center - San Francisco
Arizona
- Neuromuscular Clinical and Research Center - Phoenix
- HonorHealth Neurology - Bob Bove Neuroscience Institute - Scottsdale
Florida
- Medsol Clinical Research Center Inc - Port Charlotte
- D&H National Research Centers - Tamarac Research Center - Tamarac
Colorado
- University of Colorado - Anschutz Medical Campus - Aurora
Connecticut
- YaleNewHavenHealth - Yale New Haven Hospital - New Haven
Illinois
- Hospital Sisters Health System (HSHS) - St Elizabeth's Hospital - O'Fallon
Kansas
- The University of Kansas Health System - Landon Center on Aging - Kansas City
Maryland
- MedStar Georgetown University Hospital - Chevy Chase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 413 participants |
| Start Date | 2023-11-29 |
| Est. Completion | 2028-12-31 |
What the registry record for NCT05988073 still lists
NCT05988073 is an observational study that tracks outcomes without assigning an intervention. The registered 413 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Multifocal Motor Neuropathy appearing as the primary indexed condition, and to 0 interventions.
NCT05988073 names 20 study sites across 13 states, led by California, Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT05988073 about?
NCT05988073 is a clinical study titled "A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy". This prospective longitudinal study will follow participants with Multifocal Motor Neuropathy over time and collect data on their clinical outcomes, quality of life, and use of health care resources. Participants will follow their regular visit schedule with their treating physician, except for an o...
What is the current status of trial NCT05988073?
This trial is currently active not recruiting. The enrollment target is 413 participants. The study started on 2023-11-29. Estimated completion is 2028-12-31.
What conditions does trial NCT05988073 study?
This clinical trial studies the following conditions: Multifocal Motor Neuropathy.
Who is sponsoring clinical trial NCT05988073?
This trial is sponsored by argenx, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05988073 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multifocal Motor Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- NCT06697197 · 413 participants · Phase 1
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
- NCT04776941 · 414 participants · NA
Expressive Writing for the Management of Stress in Cancer Survivors
- NCT06792552 · 414 participants · Phase 1
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI